参考文献/References:
［1］ STRAUSBERG R L,FEINGOLD E A,GROUSE L H,et al.Gene-ration and initial analysis of more than 15 000 full-length human and mouse cDNA sequences［J］.Proc Natl Acad Sci USA,2002,99(26):16899-16903.
［2］ INGELMAN-SUNDBERG M.The human genome project and novel aspects of cytochrome P450 research［J］.Toxicol Appl Pharmacol,2005,207(2 Suppl):52-56.
［3］ KARLGREN M,GOMEZ A,STARK K,et al.Tumor-specific expression of the novel cytochrome P450 enzyme,CYP2W1［J］.Biochem Biophys Res Commun,2006,341(2):451-458.
［4］ KARLGREN M,INGELMAN-SUNDBERG M.Tumour-specific exp-ression of CYP2W1:its potential as a drug target in cancer therapy［J］.Expert Opin Ther Targets,2007,11(1):61-67.
［5］ HANZAWA Y,SASAKI T,MIZUGAKI M,et al.Genetic polymo-rphisms and haplotype structures of the human CYP2W1 gene in a Japanese population［J］.Drug Metab Dispos,2008,36(2):349-352.
［6］ QI G Z,WANG X,MIAO X J,et al.Novel single nucleotide polymor-phisms(SNPs) of CYP2W1 gene in Chinese Uygur and Han populations［J］.Drug Metab Pharmacokinet,2015,30(6):449-452.
［7］ LI Y,KANG X,YANG G,et al.Identification of genetic polymo-rphisms of CYP2W1 in the three main Chinese ethnicities:Han,Tibetan,and Uighur［J］.Drug Metab Dispos,2016,44(9):1510-1515.
［8］ GERVASINI G,DE MURILLO S G,LADERO J M,et al.CYP2W1 variant alleles in Caucasians and association of the CYP2W1 G541A(Ala181Thr) polymorphism with increased colorectal cancer risk［J］.Pharmacogenomics,2010,11(7):919-925.
［9］ STENSTEDT K,TRAVICA S,GUO J,et al.CYP2W1 polymo-rphism:functional aspects and relation to risk for colorectal cancer［J］.Pharmacogenomics,2013,14(13):1615-1622.
［10］ KOZYRA M,INGELMAN-SUNDBERG M,LAUSCHKE V M.Rare genetic variants in cellular transporters,metabolic enzymes,and nuclear receptors can be important determinants of interindividual differences in drug response［J］.Genet Med,2017,19(1):20-29.
［11］ GOMEZ A,KARLGREN M,EDLER D,et al.Expression of CYP2W1 in colon tumors:regulation by gene methylation［J］.Pharmacogenomics,2007,8(10):1315-1325.
［12］ YAN J,XIE W.A brief history of the discovery of PXR and CAR as xenobiotic receptors［J］.Acta Pharm Sin B,2016,6(5):450-452.
［13］ CHOONG E,GUO J,PERSSON A,et al.Developmental regulation and induction of cytochrome P450 2W1,an enzyme expressed in colon tumors［J］.PLoS One,2015,10(4):e0122820.
［14］ CHOUDHARY D,JANSSON I,STOILOV I,et al.Expression patterns of mouse and human CYP orthologs(families 1-4) during development and in different adult tissues［J］.Arch Biochem Biophys,2005,436(1):50-61.
［15］ KARLGREN M,MIURA S,INGELMAN-SUNDBERG M.Novel extrahepatic cytochrome P450s［J］.Toxicol Appl Pharmacol,2005,207(2 Suppl):57-61.
［16］ WU Z L,SOHL C D,SHIMADA T,et al.Recombinant enzymes overexpressed in bacteria show broad catalytic specificity of human cytochrome P450 2W1 and limited activity of human cytochrome P450 2S1［J］.Mol Pharmacol,2006,69(6):2007-2014.
［17］ YOSHIOKA H,KASAI N,IKUSHIRO S,et al.Enzymatic prope-rties of human CYP2W1 expressed in Escherichia coli［J］.Biochem Biophys Res Commun,2006,345(1):169-174.
［18］ XIAO Y,GUENGERICH F P.Metabolomic analysis and iden-tification of a role for the orphan human cytochrome P450 2W1 in selective oxidation of lysophospholipids［J］.J Lipid Res,2012,53(8):1610-1617.
［19］ ZHAO Y,WAN D,YANG J,et al.Catalytic activities of tumor-specific human cytochrome P450 CYP2W1 toward endogenous substrates［J］.Drug Metab Dispos,2016,44(5):771-780.
［20］ LI W,TANG Y,HOSHINO T,et al.Molecular modeling of human cytochrome P450 2W1 and its interactions with substrates［J］.J Mol Graph Model,2009,28(2):170-176.
［21］ GOMEZ A,NEKVINDOVA J,TRAVICA S,et al.Colorectal cancer-specific cytochrome P450 2W1:intracellular localization,glycosylation,and catalytic activity［J］.Mol Pharmacol,2010,78(6):1004-1011.
［22］ GUO J,THIESS S,JOHANSSON I,et al.Membrane topology and search for potential redox partners of colon cancer-specific cytochrome P450 2W1［J］.FEBS Lett,2016,590(3):330-339.
［23］ THOMAS R D,GREEN M R,WILSON C,et al.Cytochrome P450 expression and metabolic activation of cooked food mutagen 2-amino-1-methyl-6-phenylimidazo［4,5-b］pyridine(PhIP) in MCF10A breast epithelial cells［J］.Chem Biol Interact,2006,160(3):204-216.
［24］ EUN C Y,HAN S,LIM Y R,et al.Bioactivation of aromatic amines by human CYP2W1,an orphan cytochrome P450 enzyme［J］.Toxicol Res,2010,26(3):171-175.
［25］ NISHIDA C R,LEE M,DE MONTELLANO P R.Efficient hypoxic activation of the anticancer agent AQ4N by CYP2S1 and CYP2W1［J］.Mol Pharmacol,2010,78(3):497-502.
［26］ TAN B S,TIONG K H,MURUHADAS A,et al.CYP2S1 and CYP2W1 mediate 2-(3,4-dimethoxyphenyl)-5-fluoroben-zothiazole(GW-610,NSC 721648) sensitivity in breast and colorectal cancer cells［J］.Mol Cancer Ther,2011,10(10):1982-1992.
［27］ TRAVICA S,PORS K,LOADMAN P M,et al.Colon cancer-specific cytochrome P450 2W1 converts duocarmycin analogues into potent tumor cytotoxins［J］.Clin Cancer Res,2013,19(11):2952-2961.
［28］ SHELDRAKE H M,TRAVICA S,JOHANSSON I,et al.Re-engineering of the duocarmycin structural architecture enables bioprecursor development targeting CYP1A1 and CYP2W1 for biological activity［J］.J Med Chem,2013,56(15):6273-6277.
［29］ WANG K,GUENGERICH F P.Bioactivation of fluorinated 2-aryl-benzothiazole antitumor molecules by human cytochrome P450s 1A1 and 2W1 and deactivation by cytochrome P450 2S1［J］.Chem Res Toxicol,2012,25(8):1740-1751.
［30］ EDLER D,STENSTEDT K,OHRLING K,et al.The expression of the novel CYP2W1 enzyme is an independent prognostic factor in colorectal cancer-a pilot study［J］.Eur J Cancer,2009,45(4):705-712.
［31］ STENSTEDT K,HALLSTROM M,JOHANSSON I,et al.The expression of CYP2W1:a prognostic marker in colon cancer［J］.Anticancer Res,2012,32(9):3869-3874.
［32］ STENSTEDT K,HALLSTROM M,LDEL F,et al.The expression of CYP2W1 in colorectal primary tumors,corresponding lymph node metastases and liver metastases［J］.Acta Oncol,2014,53(7):885-891.
［33］ ZHANG K,JIANG L,HE R,et al.Prognostic value of CYP2W1 expression in patients with human hepatocellular carcinoma［J］.Tumour Biol,2014,35(8):7669-7673.
［34］ RONCHI C L,SBIERA S,VOLANTE M,et al.CYP2W1 is highly expressed in adrenal glands and is positively associated with the response to mitotane in adrenocortical carcinoma［J］.PLoS One,2014,9(8):e105855.
［35］ NOL P,DUIJNDAM B,STENMAN A,et al.Human cytochrome P450 2W1 is not expressed in adrenal cortex and is only rarely expressed in adrenocortical carcinomas［J］.PLoS One,2016,11(9):e0162379.
［36］ PAN Y,ONG E C.Cytochrome P450 2W1(CYP2W1)-ready for use as the biomarker and drug target for cancer［J］.Xenobiotica,2017,47(10):923-932.
［37］ GUO J,JOHANSSON I,MKRTCHIAN S,et al.The CYP2W1 enzyme:regulation,properties and activation of prodrugs［J］.Drug Metab Rev,2016,48(3):369-378.
［38］ CHUNG F F,MAI C W,NG P Y,et al.Cytochrome P450 2W1(CYP2W1) in colorectal cancers［J］.Curr Cancer Drug Targets,2016,16(1):71-78.
相似文献/References:
[1]朱武凌 范秉琳.青年与老年结直肠癌C—erbB一2不同表达与DNA倍体的关系[J].新乡医学院学报,2002,19(03):170.
[2]王璧,王战会,韩保卫,等.Runt相关转录因子3在结直肠癌组织中的表达及意义[J].新乡医学院学报,2022,39(12):1127.[doi:10.7683/xxyxyxb.2022.12.005]
WANG Bi,WANG Zhanhui,HAN Baowei,et al.Expression and significance of Runt-related transcription factor 3 in colorectal cancer[J].Journal of Xinxiang Medical University,2022,39(7):1127.[doi:10.7683/xxyxyxb.2022.12.005]
[3]李怡春,张 敏,杨晓煜,等.CD133在人结直肠癌组织中的表达及其与缺氧诱导因子1α和核心蛋白聚糖的相关性[J].新乡医学院学报,2019,36(11):1036.[doi:10.7683/xxyxyxb.2019.11.007]
LI Yi-chun,ZHANG Min,YANG Xiao-yu,et al.Expression of CD133 in human colorectal cancer tissues and correlation with hypoxia-induced factor-1α and decorin[J].Journal of Xinxiang Medical University,2019,36(7):1036.[doi:10.7683/xxyxyxb.2019.11.007]
[4]平贯芳,熊万成,邓智建.长链非编码RNA 浆细胞瘤转化迁移基因1在结直肠癌组织和细胞中的表达及临床意义[J].新乡医学院学报,2019,36(10):949.[doi:10.7683/xxyxyxb.2019.10.011]
PING Guan-fang,XIONG Wan-cheng,DENG Zhi-jian.Expression and clinical significance of long-chain non-coding RNA plasmacytoma variant translocation gene 1 in colorectal cancer tissues and cells[J].Journal of Xinxiang Medical University,2019,36(7):949.[doi:10.7683/xxyxyxb.2019.10.011]
[5]吕文豪,董 媛,魏子白.二甲双胍在结直肠癌治疗中的作用研究进展[J].新乡医学院学报,2021,38(7):692.[doi:10.7683/xxyxyxb.2021.07.020]
[6]姬颖华,杨晓煜,孟祥丽,等.盐酸安罗替尼联合信迪利单抗治疗标准治疗失败后微卫星稳定型结直肠癌疗效观察[J].新乡医学院学报,2021,38(8):719.[doi:10.7683/xxyxyxb.2021.08.004]
JI Yinghua,YANG Xiaoyu,MENG Xiangli,et al.Clinical efficacy of Anlotinib hydrochloride combined with Sintilimab in the treatment of microsatellite stable colorectal cancer after the failure of standard treatment[J].Journal of Xinxiang Medical University,2021,38(7):719.[doi:10.7683/xxyxyxb.2021.08.004]
[7]马 晓,陈国荣,李君艳,等.外周血中性粒细胞与淋巴细胞比值及血清癌胚抗原、糖类抗原199联合检测对结直肠癌的诊断价值[J].新乡医学院学报,2021,38(1):062.[doi:10.7683/xxyxyxb.2021.01.013]
MA Xiao,CHEN Guorong,LI Junyan,et al.Value of combined detection of neutrophil-lymphocyte ratio in peripheral blood,serum carcinoembryonic antigen and carbohydrate antigen 199 in the diagnosis of colorectal cancer[J].Journal of Xinxiang Medical University,2021,38(7):062.[doi:10.7683/xxyxyxb.2021.01.013]
[8]谢 阳,赵李红,杨昌建,等.不同肺复张策略治疗腹腔镜下结直肠癌根治术患者围手术期肺不张疗效观察[J].新乡医学院学报,2021,38(9):857.[doi:10.7683/xxyxyxb.2021.09.012]
XIE Yang,ZHAO Lihong,YANG Changjian,et al.Effect of different lung recruitment strategies in treatment of perioperative atelectasis of patients undergoing laparoscopic radical resection of colorectal cancer[J].Journal of Xinxiang Medical University,2021,38(7):857.[doi:10.7683/xxyxyxb.2021.09.012]
[9]胡德升,高 磊,王 江,等.外周血胸苷酸合成酶基因表达与中晚期结直肠癌患者FOLFOX4化学治疗敏感性和预后的相关性[J].新乡医学院学报,2020,37(10):930.[doi:10.7683/xxyxyxb.2020.10.007]
HU Desheng,GAO Lei,WANG Jiang,et al.Correlation between thymidylate synthase gene expression in peripheral blood and FOLFOX4 chemotherapy sensitivity and prognosis of patients with advanced colorectal cancer[J].Journal of Xinxiang Medical University,2020,37(7):930.[doi:10.7683/xxyxyxb.2020.10.007]
[10]王 鑫,王 钊,李元春,等.热休克蛋白70及基质金属蛋白酶-7和EHD2蛋白在结直肠癌组织中的表达及意义[J].新乡医学院学报,2019,36(5):443.[doi:10.7683/xxyxyxb.2019.05.010]
WANG Xin,WANG Zhao,LI Yuan-chun,et al.Expression and significance of heat shock protein 70，matrix metalloproteinase-7 and EHD2 in colorectal cancer tissues[J].Journal of Xinxiang Medical University,2019,36(7):443.[doi:10.7683/xxyxyxb.2019.05.010]